| Revolution Medicines Inc | 2,375,000 | 231M $ | |
| BioMarin Pharmaceutical Inc | 3,575,000 | 202M $ | |
| Abivax SA | 1,500,000 | 167M $ | |
| Neurocrine Biosciences Inc | 1,250,000 | 164.7M $ | |
| Arrowhead Pharmaceuticals Inc | 2,275,000 | 142.6M $ | |
| Enliven Therapeutics Inc | 3,250,000 | 127.4M $ | |
| Repligen Corp | 925,000 | 109M $ | |
| Bicara Therapeutics Inc | 5,425,000 | 107.9M $ | |
| Nurix Therapeutics Inc | 6,500,000 | 100.8M $ | |
| Apogee Therapeutics Inc | 1,100,000 | 92.6M $ | |
| Ascendis Pharma A/S | 375,000 | 85.8M $ | |
| Immunocore Holdings PLC | 2,766,868 | 83.4M $ | |
| Taysha Gene Therapies Inc | 18,000,000 | 80.5M $ | |
| Dyne Therapeutics Inc | 4,000,000 | 72.5M $ | |
| Sanofi SA | 1,400,000 | 67.5M $ | |
| BioCryst Pharmaceuticals Inc | 7,025,000 | 66.9M $ | |
| Scholar Rock Holding Corp | 1,324,422 | 65.1M $ | |
| Bristol-Myers Squibb Co | 1,000,000 | 60.7M $ | |
| Monte Rosa Therapeutics Inc | 3,603,465 | 59.3M $ | |
| Vera Therapeutics Inc | 1,368,159 | 55M $ | |
| Terns Pharmaceuticals Inc | 1,000,000 | 52.7M $ | |
| Globus Medical Inc | 610,520 | 52.6M $ | |
| Boston Scientific Corp | 800,000 | 50.2M $ | |
| Nuvalent Inc | 481,715 | 49.4M $ | |
| Cogent Biosciences Inc | 1,230,888 | 47.4M $ | |
| Alto Neuroscience Inc | 2,064,075 | 46.4M $ | |
| Rapport Therapeutics Inc | 1,436,229 | 44.9M $ | |
| Disc Medicine Inc | 700,000 | 44.8M $ | |
| United Therapeutics Corp | 75,000 | 44.5M $ | |
| Celldex Therapeutics Inc | 1,224,165 | 38.8M $ | |
| KalVista Pharmaceuticals Inc | 1,850,000 | 37.2M $ | |
| Solid Biosciences Inc | 5,000,000 | 36M $ | |
| Protagonist Therapeutics Inc | 326,159 | 34.4M $ | |
| Denali Therapeutics Inc | 1,773,326 | 34M $ | |
| Regeneron Pharmaceuticals, Inc. | 40,000 | 30.9M $ | |
| Waters Corp | 100,000 | 29.8M $ | |
| Viking Therapeutics Inc | 914,147 | 29.7M $ | |
| Inspire Medical Systems Inc | 539,269 | 27.8M $ | |
| Trevi Therapeutics Inc | 2,166,504 | 25.8M $ | |
| Lexeo Therapeutics Inc | 4,475,000 | 25.7M $ | |
| Soleno Therapeutics Inc | 730,000 | 24.4M $ | |
| Beta Bionics Inc | 2,211,518 | 22.2M $ | |
| Nektar Therapeutics | 285,000 | 20.5M $ | |
| Cytokinetics Inc | 300,000 | 19.8M $ | |
| West Pharmaceutical Services Inc | 75,000 | 18.8M $ | |
| GE HealthCare Technologies Inc | 250,000 | 17.8M $ | |
| SpyGlass Pharma Inc | 666,760 | 17.3M $ | |
| Zimmer Biomet Holdings Inc | 190,000 | 17.2M $ | |
| Madrigal Pharmaceuticals Inc | 31,468 | 16.5M $ | |
| GeneDx Holdings Corp | 250,000 | 16.1M $ | |
| DAMORA THERAPEUTICS INC | 600,000 | 15.5M $ | |
| Agios Pharmaceuticals Inc | 450,000 | 15.2M $ | |
| Savara Inc | 2,600,052 | 14.2M $ | |
| Tarsus Pharmaceuticals Inc | 200,000 | 14M $ | |
| Voyager Therapeutics Inc | 3,002,936 | 11.6M $ | |
| Insulet Corp | 50,601 | 10.6M $ | |
| Tectonic Therapeutic Inc | 328,000 | 10.1M $ | |
| Surrozen Inc | 338,611 | 9.9M $ | |
| Arvinas Inc | 905,465 | 9.6M $ | |
| MapLight Therapeutics Inc | 420,000 | 8.5M $ | |
| Fulcrum Therapeutics Inc | 1,100,000 | 8.4M $ | |
| OnKure Therapeutics Inc | 1,839,819 | 7.6M $ | |
| Myriad Genetics Inc | 1,648,000 | 7.4M $ | |
| Olema Pharmaceuticals Inc | 428,551 | 6.4M $ | |
| Anteris Technologies Global Corp | 1,144,780 | 6.4M $ | |
| Candel Therapeutics Inc | 1,125,000 | 5.5M $ | |
| Palisade Bio Inc | 2,500,000 | 4.4M $ | |
| Veracyte Inc | 130,687 | 4.2M $ | |
| ZENAS BIOPHARMA INC | 200,000 | 3.9M $ | |
| Geron Corp | 2,540,000 | 3.8M $ | |
| Monopar Therapeutics Inc | 65,418 | 3.6M $ | |
| Passage Bio Inc | 305,000 | 2.4M $ | |
| Tyra Biosciences Inc | 54,000 | 2.1M $ | |
| REGENXBIO Inc | 108,525 | 909.4K $ | |
| Tenax Therapeutics Inc | 53,439 | 854.5K $ | |
| MacroGenics Inc | 280,000 | 809.2K $ | |
| Absci Corp | 232,219 | 696.7K $ | |
| APREA THERAPEUTICS INC | 350,000 | 267K $ | |